Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q4 2024 Earnings Call Transcript February 28, 2025
Operator: Good afternoon, everyone. Welcome to the Crinetics Pharmaceuticals Fourth Quarter and Full-Year 2024 Financial Results Conference Call. [Operator Instructions] Also, today’s call is being recorded. With that, I’ll turn things over to Gayathri Diwakar, Head of Investor Relations. Please go ahead, Ma’am.
Gayathri Diwakar: Thank you, operator. Good afternoon, everyone, and, thank you for...
